Laboratory testing for hepatitis C

Brazilian Journal of Infectious Diseases

Volumn 11, Issue SUPPL. 1, 2007, Pages 22-24

  Gonçales, Neiva Sellan Lopes ^a   Gonçales Jr , Fernando Lopes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS PROTEIN; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; MEDICAL DECISION MAKING; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; VIRUS PARTICLE;

EID: 36949025895     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000700008     Document Type: Article

References (28)

1. Alter M.J., Kuhnert W.L., Finelli L. Guidelines for Laboratory Testing and Result Reporting of antibody to hepatitis C Virus. MMWR 2003; 52:1-15.
2. Kleinman S., Alter H., Bush M., et al. Increased detection of hepatitis C virus (HCV) - infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-613.
3. Conry-Cantilena C., VanRaden M., Gibble J., et al. Route of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
4. Hyams K.C., Riddle J., Rubertone M., et al. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21000 troops. Am J Epidemiol 2001;153:764-70.
5. Busch M.P., Kleinmam S.H., Jackson B., et al. Nucleic acid testing of blood donors for transfusion-transmitted infectious diseases: report of Interorganization Task Force on Nucleic Acid Amplification of Blood Donors. Transfusion 2000;40:143-59.
6. Thomas D.L., Astemborski J., Rai R.M., et al. Natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284:450-6.
7. Alter M.J., Margolis H.S., Krawczynski K., et al. Natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
8. Larghi A., Zuin M., Crosignani A., et al. Outcome of an out break of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002;36:993-1000.
9. Alter H.J., Seef L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long term outcome. Semin Liver Dis 2000;20:17-35.
10. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-68.
11. Pawlotsky J.M. Use and interpretation ofvirological tests for hepatitis C. Hepatology 2002;36:S65-S73.
12. Callendo A.M., Valsamakis A., Zhou Y., et al. Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 2006; 44:1726-32.
13. Gonçales N.S.L., Costa F.F., Vassalo J., Gonçales Jr., F.L. Diagnosis of hepatitis C in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme inummoassay and recombinant protein immunoblot assay. Rev Inst Med trop S Paulo 2000;42(5):263-7.
14. Lakshmi V., Reddy A.K., Dakshinamurty K.V. Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis. Indian J Med Microbiol 2007;25:140-2.
15. Tanaka E.C., Ohue K., Aoyagi K., et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000;32:388-93.
16. Laperche S., Le Marrec N., Simon N., et al. A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 2003; 43:958-62.
17. Laperche S., Elghouzzi M.-H., More P., et al. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion 2005; 45:1965-72.
18. Laperche S., Le Marrec N., Girault A., et al.. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005; 43:3877-83.
19. Desombere I., Van Vlierberghe H., Couvert S., et al. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections. J Clin Microbiol 2005;43(6):2590-2.
20. Elbeik T, Surtihadi J, Destree M et al. Multicenter evaluation of performance characteristics of the Bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol 2004;42:563-9.
21. Veillon P., Payan C., Picchio G., et al. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and Amplicor Monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribarin combination therapy. J Clin Microbiol 2003;41:3212-20.
22. Nolte F.S., Fried M.W., Shiffman M.L., et al. Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol 2001;39:4005-12.
23. Konnick E.Q., Willians S., Ashwood E.R., et al. Evaluation of Cobas hepatitis C virus (HCV) Taqman anlyte -specific reagent assay nd comparison to the Cobas Amplicor HCV monitor v2.0 and Versant HCV bDNA 3.0 assays. J Clin Microbiol 2005;43:2133-40.
24. Fried M.W., Shiffman M.L., Reddy C., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-92.
25. Shiffman M.L., Ferreira-Gonzalez A., Reddy K.R., et al. Comparison of three commercially available assays for HCV RNA using the International Units standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practice. Am J Gastroenterol 2003;98:1159-66.
26. Podzorski R.P. Molecular testing in the diagnosis and management of hepatitis C virus infection. Arch Pathol Lab Med 2002;126:285-90.
27. Schirm J., van Loon A.M., Valentine-Thon E., et al. External quality assessment program for qualitative and quantitative detection of hepatitis C virus in diagnostic virology. J Clin Microbiol 2002; 40:2973-80.
28. Pawlotsky J.M. Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics. Semin Liver Dis 2003;23:3-11.